drugset / Trial / NCT05939193

Effect of Urine-guided Hydration on Acute Kidney Injury After CRS-HIPEC

NCT05939193

RandomizedParallel-groupTriple-blindPrevention

Summary

Acute renal injury (AKI) is a common complication after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC), and is associated with worse outcomes. Available evidences show that maintaining intraoperative urine output ≥ 200 ml/h by fluid and furosemide administration may reduce the incidence of AKI in patients undergoing cardiopulmonary bypass. The investigators hypothesize that, for patients undergoing CRS-HIPEC, intraoperative urine-volume guided hydration may also reduce the incidence of postoperative AKI.

Timeline

Start
2023-07-24
Primary completion
2024-07-19
Completion
2025-02-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Furosemide Other / unclassified 10 mg Intravenous

Indications